Back to results
US 2022/0025047 A1Published application
Cd3 binding antibodies
AssigneeTeneoBio, Inc.
InventorsNathan Trinklein, Wim van Schooten, Shelley Force Aldred, Katherine Harris, Duy Pham
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.
Claims18
-38. (canceled)
A bispecific three-chain antibody like molecule comprising:
- (a) a first binding moiety specific for CD3, wherein the first binding moiety comprises:
- (i) a first polypeptide subunit comprising a heavy chain variable (VH) domain comprising a CDR1 having an amino acid sequence of GFTFDDYA (SEQ ID NO:29), a CDR2 having an amino acid sequence of ISWNSGSI (SEQ ID NO:24), and a CDR3 having an amino acid sequence of AKDSRGYGDYRLGGAY (SEQ ID NO:
- 41);
- and
- (ii) a second polypeptide subunit comprising a light chain variable (VL) domain comprising a CDR1 having an amino acid sequence of QSVSSN (SEQ ID NO:
- 35), a CDR2 having an amino acid sequence of GAS (SEQ ID NO:
- 38), and a CDR3 having an amino acid sequence of QQYNNWPWT (SEQ ID NO:
- 45);
- and
- (b) a second binding moiety specific for BCMA, wherein the second binding moiety comprises:
- (i) a third polypeptide subunit comprising a VH domain comprising a CDR1 having an amino acid sequence of GFTVSSYG (SEQ ID NO:36), a CDR2 having an amino acid sequence of IRGSDGST (SEQ ID NO:39), and a CDR3 having an amino acid sequence of AKQGENDGPFDH (SEQ ID NO:46).
8 more elements
A bispecific three-chain antibody like molecule comprising:
- (a) a first binding moiety specific for CD3, wherein the first binding moiety comprises a first polypeptide subunit comprising a VH domain having an amino acid sequence of SEQ ID NO:1 and a second polypeptide subunit comprising a VL domain having an amino acid sequence of SEQ ID NO:19;
- and
- (b) a second binding moiety specific for BCMA, wherein the second binding moiety comprises a third polypeptide subunit comprising a VH domain having an amino acid sequence of SEQ ID NO:21.
A bispecific three-chain antibody like molecule comprising:
- (a) a first binding moiety specific for CD3, wherein the first binding moiety comprises a first polypeptide subunit comprising a VH domain having an amino acid sequence of SEQ ID NO:1 and a second polypeptide subunit comprising a VL domain having an amino acid sequence of SEQ ID NO:19;
- and
- (b) a second binding moiety specific for BCMA, wherein the second binding moiety comprises a third polypeptide subunit has an amino acid sequence of SEQ ID NO:20.
Dependencies are inferred from the claim text.